Clinical Trials Logo

Clinical Trial Summary

Meralgia paresthetica is an entrapment neuropathy of the lateral femoral cutaneous nerve. Its main manifestation is neuropathic pain on the lateral aspect of the thigh. Neural prolotherapy has shown improvement and relieve of neuropathic pain.

The aim of the current study was to assess the efficacy of neural prolotherapy (subcutaneous perineural injection of dextrose 5% solution) on reliving pain and improvement of function and quality of life in patients with meralgia paresthetica.


Clinical Trial Description

Meralgia paresthetica is a mononeuropathy of the lateral femoral cutaneous nerve (i.e. lateral cutaneous nerve of the thigh). It is known as the lateral cutaneous nerve of the thigh neuralgia. It is due to a lot of etiologies. It is characterized by neuropathic pain, tingling, paresthesia and numbness in the anterolateral aspect of the thigh. The symptoms may be provoked or worsened by prolonged standing and walking. Sitting may alleviate the pain because there is reduction of the tension over the nerve, The treatment of meralgia paresthetica is directed towards the improvement of the symptoms which is mainly pain with subsequent improvement of function and quality of life, as well as, treatment of the etiology. The treatment includes conservative and surgical treatment. Conservative treatment consists of non-pharmacologic treatment and pharmacologic treatment. Surgical treatment takes place in case of failure of the conservative treatment. Surgical options consist of neurolysis and neurectomy.

Neural prolotherapy was reported to improve and relieve of neuropathic pain including that of meralgia paresthetica. Neural prolotherapy is the subcutaneous perineural injection of isotonic dextrose (5%) solution especially at the points of fascial penetration of the sensory nerve. It is the site where the sensory nerve reaches the subcutaneous plane. There are scanty studies assessed this issue.

The aim of the current study was to assess the efficacy of neural prolotherapy (subcutaneous perineural injection of dextrose 5% solution) on reliving pain and improvement of function and quality of life in patients with meralgia paresthetica. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04499911
Study type Interventional
Source University of Alexandria
Contact
Status Completed
Phase N/A
Start date April 15, 2018
Completion date September 30, 2019

See also
  Status Clinical Trial Phase
Completed NCT04747119 - Effect of MET on Meralgia Paraesthesia Postpartum "Muscle Energy Technique" N/A
Completed NCT06187883 - Pulsed Radiofrequency of Lateral Femoral Cutaneous Nerve
Completed NCT02577510 - Comparing Ways to Freeze the Nerve That Provides Thigh Sensation Phase 3
Withdrawn NCT04046406 - Pelvic Pain Treated With MR-guided Cryoanalgesia N/A
Recruiting NCT05893732 - HILT for Meralgia Paresthetica: A Randomized Controlled Trial N/A
Completed NCT06251882 - Efficacy of Ultrasound-guided Injection of 5% Dextrose for Meralgia Paresthesia N/A
Completed NCT04004052 - Conservative Treatment and Ultrasound Guided Injection for Treatment Meralgia Paresthetica N/A